NeurologyLive Friday 5 — February 14, 2020

Article

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 14, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Podcast: No Relief for Rising MS Drug Prices

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Daniel Hartung, PharmD, MPH.

LISTEN NOW

2: New Guidelines for Addressing Sleep Disturbance in Autism Spectrum Disorder

Following the 2011 guideline development process, this 2020 guideline focused on addressing a number of types of sleep disturbance in children and adolescents with autism spectrum disorder.

READ MORE

3: Can Better Stress Coping Limit Tau Deposition?

Stress coping abilities may have a direct impact on the early accumulation of tau pathology.

READ MORE

4: Advice for Neurologists Treating Patients With Sialorrhea

Expert panelists provide advice to neurologists to incorporate the use of botulinum toxic injections into their practice to treat sialorrhea in Parkinson disease.

WATCH NOW

5: Smartphones in the Clinic: How Patient Videos Can Change Seizure Diagnosis

William O. Tatum, DO, director, Comprehensive Epilepsy Center, and professor of neurology, Mayo Clinic College of Medicine & Health Sciences, discussed the additive value of smartphone video technology in diagnosing epilepsy.

READ MORE

Related Videos
Justin Moy
Diana Castro, MD
Marjan Gharagozloo, PhD
 Jeffrey Huang, PhD
Shiv Saidha, MBBCh
Julie Fiol, MSCN; Andreina Barnola, MD, MPH
Amaal Starling, MD, FAHS, FAAN
Lars Alfredsson, PhD
Ava Easton, PhD
© 2024 MJH Life Sciences

All rights reserved.